| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/11/2001 | WO2000061608A3 Low-molecular inhibitors of complement proteases |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000054729A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/11/2001 | WO2000051546A3 Bupropion metabolites and methods of their synthesis and use |
| 01/11/2001 | CA2643231A1 Norepinephrine reuptake inhibitors and methods of using the same |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/10/2001 | EP1066377A1 Methods for prevention and treatment of cancer |
| 01/10/2001 | EP1066304A1 Macrolide lhrh antagonists |
| 01/10/2001 | EP1066297A1 Phosphinic acid derivatives |
| 01/10/2001 | EP1066286A1 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors |
| 01/10/2001 | EP1066284A1 Benzo c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 01/10/2001 | EP1066283A2 Substituted indolealkanoic acids |
| 01/10/2001 | EP1066268A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 01/10/2001 | CN1279691A Antibodise against phosphorylated VASP (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279680A Imidazole derivatives with inhabiting activity to transterasa and preparing method thereof |
| 01/10/2001 | CN1279669A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 01/10/2001 | CN1279666A NPY antagonists |
| 01/10/2001 | CN1279612A Modulation of immune responses |
| 01/10/2001 | CN1279106A Detoxicating, Stasis-dispersing, inflammation-relieving, antalgic and refreshing medicine and its preparing process |
| 01/09/2001 | US6172237 Process for preparing eprosartan |
| 01/09/2001 | US6172102 Pyrrole derivatives and medicinal composition |
| 01/09/2001 | US6172096 Administering 4-pyrazolylbenzenesulfonamide derivatives to treat autoimmune diseases |
| 01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 01/09/2001 | US6172060 Therapy for sexual disorders |
| 01/09/2001 | US6172041 Nervous system disorders |
| 01/09/2001 | US6171598 GTP cyclohydrolase II (RIBA) |
| 01/04/2001 | WO2001000830A1 Sgip peptides |
| 01/04/2001 | WO2001000676A1 Somatostatin agonists |
| 01/04/2001 | WO2001000658A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/04/2001 | WO2001000655A2 Therapeutic peptides derived from subsequences of bpi |
| 01/04/2001 | WO2001000618A1 Benzamide derivatives |
| 01/04/2001 | WO2001000244A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 01/04/2001 | WO2001000210A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | WO2001000188A2 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and their use for preventing and/or treating anaemia |
| 01/04/2001 | WO2001000183A2 COMBINATION OF MTP INHIBITORS AND HMG-CoA REDUCTASE INHIBITORS AND THE USE THEREOF IN MEDICAMENTS |
| 01/04/2001 | WO2001000015A1 Goodpasture's syndrome model mouse |
| 01/04/2001 | WO2000060082A3 Vesicle associated proteins |
| 01/04/2001 | WO2000044761A3 Ketolide antibiotics |
| 01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 01/04/2001 | WO2000020358B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
| 01/04/2001 | DE19929785A1 Tetrahydrochinolinyl-6-methyldihydrothiadiazinon-Derivate und ihre Verwendung Tetrahydroquinolinyl-6-methyldihydrothiadiazinon derivatives and their use |
| 01/04/2001 | CA2377721A1 Sgip peptides |
| 01/04/2001 | CA2377265A1 Somatostatin agonists |
| 01/04/2001 | CA2376891A1 Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof |
| 01/04/2001 | CA2376881A1 Combination of mtp inhibitors and hmg-coa reductase inhibitors and the use thereof in medicaments |
| 01/04/2001 | CA2375952A1 Reverse-turn mimetics and methods relating thereto |
| 01/04/2001 | CA2365341A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/03/2001 | EP1065207A1 Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them |
| 01/03/2001 | EP1064965A2 Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors |
| 01/03/2001 | EP1064964A2 Compositions containing aldose reductase inhibitors and selective cyclooxygenase inhibitors for the treatment of diabetic complications |
| 01/03/2001 | EP1064951A2 Erythropoietin derivatives |
| 01/03/2001 | EP1064949A2 Compositions containing aldose reductase inhibitors and selective cyclooxygenase inhibitors for the treatment of diabetic complications |
| 01/03/2001 | EP1064306A1 $i(NEPHRIN) GENE AND PROTEIN |
| 01/03/2001 | EP1064303A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 01/03/2001 | EP1064262A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 01/03/2001 | EP1064256A1 Bicyclo [2.2.1] heptanes and related compounds |
| 01/03/2001 | EP1064254A2 Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents |
| 01/03/2001 | EP1063996A1 Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin v receptors, even of v 1a? and v 2? receptors |
| 01/03/2001 | EP1063987A1 Dietary control of arachidonic acid metabolism |
| 01/03/2001 | EP1063983A1 Transdermal therapeutic system (tts) containing oxybutynin |
| 01/03/2001 | EP0815126B1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
| 01/03/2001 | CN1278822A 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/03/2001 | CN1278810A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278809A Substituted benzodihydropyran derivatives |
| 01/03/2001 | CN1278805A Novel heterocyclioally substituted and a-hydroxycarboxlic acid derivatives, method for producing the same and their use as endothelin receptor antagonists |
| 01/03/2001 | CN1278802A Benzoxazine and Benzothiazine derivatives and their use in pharmaceuticals |
| 01/03/2001 | CN1278794A Substituted di-hydroxyl-indol derivatives as protein tyrosine kinase and as protein serine/threenine kinase inhibitors |
| 01/03/2001 | CN1278735A Vaginal suppository vaccine for urogenital infections |
| 01/03/2001 | CN1278726A IL-8 receptor antagonists |
| 01/03/2001 | CN1278721A IL-8 receptor antagonists |
| 01/03/2001 | CN1060178C Derivatives of structurally modified vip and pharmacetical compositions containing them for treating servual impotense of male |
| 01/03/2001 | CN1060171C Substituted biphenyl isoxazole sulfonamides |
| 01/03/2001 | CN1060086C Traditional Chinese medicine capsule for eliminating indurated goiter |
| 01/03/2001 | CN1060061C Pills for recovering prostate disease |
| 01/03/2001 | CN1060039C Inhibition of smooth muscle cell migration by (R)-amlodipine |
| 01/02/2001 | US6169105 Potentiating the action of paroxetine in increasing the availability of serotonin, norepinephrine and dopamine in the brain by administering paroxetine to a patient in need thereof in combination with way 100635 |
| 01/02/2001 | US6169093 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia |
| 01/02/2001 | US6169090 Heterocyclic compounds and their therapeutic use |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 01/02/2001 | CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
| 12/30/2000 | CA2313131A1 Compositions and treatment for diabetic complications |
| 12/30/2000 | CA2313105A1 Treatment for diabetic complications |
| 12/30/2000 | CA2313063A1 Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors |
| 12/28/2000 | WO2000078953A2 Human transport proteins |
| 12/28/2000 | WO2000078952A2 Human rna metabolism proteins (rmep) |
| 12/28/2000 | WO2000078768A1 Potassium channel openers |
| 12/28/2000 | WO2000078765A2 CHROMENO[4,3,2-de]ISOQUINOLINES AS POTENT DOPAMINE RECEPTOR LIGANDS |
| 12/28/2000 | WO2000078762A1 Indoloazepines as vasopressin receptor antagonists |
| 12/28/2000 | WO2000078346A1 Novel anti-allergic agents |
| 12/28/2000 | WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders |
| 12/28/2000 | WO2000078338A1 Compositions for promoting passive elongation of vesical smooth muscle |
| 12/28/2000 | WO2000078322A2 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions |
| 12/28/2000 | WO2000078319A1 Dihydropyrazine derivatives as npy antagonists |
| 12/28/2000 | WO2000078318A1 Medicinal composition for oral administration |
| 12/28/2000 | WO2000078247A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 12/28/2000 | WO2000078145A1 Macrophage scavenger receptor antagonists |